Trans American Aquaculture (GRPS) Cost of Revenue (2023 - 2024)

Trans American Aquaculture (GRPS) reported Cost of Revenue of -$98236.0 for Q4 2024, down 137.55% on a YoY basis from $261591.0 in Q1 2024, and down 149.98% quarter-over-quarter from $196552.0 in Q3 2024.

Trans American Aquaculture (GRPS) Cost of Revenue (2023 - 2024) Analysis & Trends

Trans American Aquaculture has reported Cost of Revenue for 2 years, with the latest figure at -$98236.0 in Q4 2024.

  • For the quarter ending Q4 2024, Cost of Revenue fell 137.55% year-over-year to -$98236.0; the trailing twelve-month figure through Sep 2025 stood at -$98236.0 (down 113.42% YoY), and the FY2024 full-year result was $321615.0, down 51.39% from the prior year.
  • Cost of Revenue for Q4 2024 stood at -$98236.0, down from $196552.0 in the prior quarter.
  • The five-year high for Cost of Revenue was $400000.0 in Q3 2023, with the low at -$98236.0 in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 696.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 641.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 133.40 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 34.44 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 13.80 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 586.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 155.56 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 52.68 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 222.00 Mn
10 Trans American Aquaculture - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -98,236.00
Dec 31, 2024 -98,236.00
Sep 30, 2024 196,552.00
Sep 30, 2024 196,552.00
Jun 30, 2024 1,771.00
Jun 30, 2024 1,771.00
Mar 31, 2024 272,079.00
Mar 31, 2024 272,079.00
Dec 31, 2023 261,591.00
Dec 31, 2023 261,591.00
Sep 30, 2023 400,000.00
Sep 30, 2023 400,000.00